MARKET COMPOSITE
ABBV - Abbvie Inc8:00:02 PM 5/3/2024
Price
$160.81
-0.91 (-0.56%)
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. The new Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer. The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange on January 2, 2013.
Financials
Quarterly financials
(USD)Mar 2024Q/Q
Revenue12.3B-14%
Gross Profit8.2B-
Cost Of Revenue4.1B-28%
Operating Income2.8B-12%
Operating Expenses5.4B-
Net Income1.4B+67%
R&D1.9B+1%
G&A3.3B+4%
Amortization1.9B-0%
Interest Expense660MM+17%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news